FORMULATION AND DEVELOPMENT OF KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION
Abstract
An acetic acid derivative ketorolac tromethmine has found its applicability in both gram positive and gram negative bacterial ocular infection and used commonly associated with multiple doses. Ophthalmic medication stored in multiple dose containers is required by the U.S. Food and Drug Administration to contain a preservative so that patients are provided with microbe free medication. Benzalkonium chloride in concentrations from 0.1% to 0.0001% induced dose-dependent growth arrest and conjunctiva epithelial cell death, either delayed or immediately after administration. In such case, a preservative Benzalkonium chloride must be used within reasonable bound. Benzalkonium chloride can provide more help than harm. Hence the present study focusing on to formulate a formulation for ketorolac tromethmine (0.5%) ophthalmic solution using different concentration of Benzalkonium chloride as preservative.
Keywords: Ketorolac tromethamine, Ophthalmic, benzalkonium chloride, conjunctiva
DOI
https://doi.org/10.22270/jddt.v8i3.1710References
Baveja, S. K., Ranga – Rao, K. V. and Padmalatha Devi, K., Zero order release hydrophilic eye drops of adrenergic blockers, Int. J. Pharm., 1997; 39:39-45
Diao, Y. Tu, XD.,Development and pharmacokinetic study of miocamycin sustained release Ocular drug delivery system, Acta Pharmaceutica Sinica. 1991; 26 (Sep): 695-700.
Du, K. Chen, SX. Zhu, JB., Eye drops of zomepirac sodium with cellulose acetate.,J. of Pharm. Sci. 1989;60 (Jan): 276-278.
Du, Q. Fan, C. Sun, YL., Preparation and Ocular in vitro evaluation of multiple unit floating granules of aminophylline., Chinese J. of Hospital Pharm. 1996; 16(Feb):54- 56.
Altaf, S. and Jones D. B., Development of ophthalmic sustained release formulation of Prednisolone , Pharm. Res., 1998; 15:119 – 1201.
Abrahamsson, B., Alpsten, M., Bake, B., Larsson, A. and Sjogren, J., In-vitro and in-vivo erosion of two different hydrophilic Ocular drug delivery system, Eur. J. Pharm. Biopharm., 1998; 46(1): 69 – 75.
Shivakumar H.G., Vishakante Gowda D. and Pramod Ku. T.M., “occular controlled drug delivery systems for prolonged occular residence: A review†Ind. J. Pharm. Educ. 2004; 38(4):177.
Choi, BY. Park, HJ. Hwang, SJ. Park, JB., Preparation of alginate beads for Ocular drug delivery system : effects of CO(2) gas-forming agents., Int. J. of Pharm. 2002; 239(Jun):81-91.
Timmermans J, Moes AJ, “Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversyâ€, J. Pharm. Sci., 2008, 18-24.
PMojaverian P, Vlasses PH, Kellner PE, Rocci ML, Jr., “Effects of gender, posture, age on gastric residence time of an indigestible solids: pharmaceutical considerationsâ€, Pharm. Res., 2010; 10: 639-644.
Panchal HA, Tiwari AK. Novel Approach of Ocular Drug Delivery Technology: An Review. Journal of Pharmaceutical Science and Technology 2012; 4(4):892–904.
Divya A, Kavitha K, Kumar MR, Dakshayani S, Jagadeesh SSD. Ocular Drug Delivery System: An overview. Journal of Applied Pharmaceutical Science 2011; 01(08):43-47
Shiyani B, Gattani S, Surana S. Formulation and evaluation of Ciprofloxacin eye drops AAPS Pharm Sci Tech 2008 ; 9(3):818-27
Deshpande RD, Gowda DV, Mahammed N, Deepak N. Maramwar. Conjuctival eye disorder: a review. IJPSR 2011; 2(10): 2534-2544
European Society of Ocular Diseases -European Society of Opthalmology guidelines for the management of conjuctival disorders. 2003; 21:1011–1053.
Published
Abstract Display: 1095 
PDF Downloads: 1144 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.